Clinical Trial Update: Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating omalizumab for treating food allergy in patients with elevated total IgE levels; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Allergy

Drugs mentioned

• Omalizumab (Omalizumab)

Snippet

Sponsor: Johns Hopkins University | Conditions: Food Hypersensitivity | Phase 2 | Status: RECRUITING